Peng Sheng-Yao, Tang Jen-Yang, Li Ruei-Nian, Huang Hurng-Wern, Wu Chang-Yi, Chiu Chien-Chih, Chang Fang-Rong, Zhang Hong-Wei, Lee Yun-Jou, Sheu Jyh-Horng, Chang Hsueh-Wei
PhD Program in Life Science, Department of Biomedical Science and Environmental Biology, College of Life Science, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
School of Post-Baccalaureate Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Cancers (Basel). 2021 May 18;13(10):2450. doi: 10.3390/cancers13102450.
Combined treatment is increasingly used to improve cancer therapy. Non-ionizing radiation ultraviolet-C (UVC) and sinularin, a coral -derived cembranolide, were separately reported to provide an antiproliferation function to some kinds of cancer cells. However, an antiproliferation function using the combined treatment of UVC/sinularin has not been investigated as yet. This study aimed to examine the combined antiproliferation function and explore the combination of UVC/sinularin in oral cancer cells compared to normal oral cells. Regarding cell viability, UVC/sinularin displays the synergistic and selective killing of two oral cancer cell lines, but remains non-effective for normal oral cell lines compared to treatments in terms of MTS and ATP assays. In tests using the flow cytometry, luminescence, and Western blotting methods, UVC/sinularin-treated oral cancer cells exhibited higher reactive oxygen species production, mitochondrial superoxide generation, mitochondrial membrane potential destruction, annexin V, pan-caspase, caspase 3/7, and cleaved-poly (ADP-ribose) polymerase expressions than that in normal oral cells. Accordingly, oxidative stress and apoptosis are highly induced in a combined UVC/sinularin treatment. Moreover, UVC/sinularin treatment provides higher G2/M arrest and γH2AX/8-hydroxyl-2'deoxyguanosine-detected DNA damages in oral cancer cells than in the separate treatments. A pretreatment can revert all of these changes of UVC/sinularin treatment with the antioxidant -acetylcysteine. Taken together, UVC/sinularin acting upon oral cancer cells exhibits a synergistic and selective antiproliferation ability involving oxidative stress-dependent apoptosis and cellular DNA damage with low toxic side effects on normal oral cells.
联合治疗越来越多地用于改善癌症治疗。非电离辐射紫外线C(UVC)和来自珊瑚的西松烷型二萜类化合物西诺灵,分别被报道对某些癌细胞具有抗增殖作用。然而,UVC/西诺灵联合治疗的抗增殖作用尚未得到研究。本研究旨在检测UVC/西诺灵联合治疗的抗增殖作用,并探索其在口腔癌细胞与正常口腔细胞中的联合作用。关于细胞活力,UVC/西诺灵对两种口腔癌细胞系具有协同和选择性杀伤作用,但与MTS和ATP检测的单一治疗相比,对正常口腔细胞系仍无作用。在使用流式细胞术、发光和蛋白质印迹法的试验中,UVC/西诺灵处理的口腔癌细胞比正常口腔细胞表现出更高的活性氧生成、线粒体超氧化物生成、线粒体膜电位破坏、膜联蛋白V、泛半胱天冬酶、半胱天冬酶3/7和裂解的聚(ADP-核糖)聚合酶表达。因此,UVC/西诺灵联合治疗可高度诱导氧化应激和细胞凋亡。此外,与单一治疗相比,UVC/西诺灵治疗在口腔癌细胞中导致更高的G2/M期阻滞和γH2AX/8-羟基-2'-脱氧鸟苷检测到的DNA损伤。用抗氧化剂N-乙酰半胱氨酸预处理可以逆转UVC/西诺灵治疗的所有这些变化。综上所述,UVC/西诺灵作用于口腔癌细胞表现出协同和选择性抗增殖能力,涉及氧化应激依赖性细胞凋亡和细胞DNA损伤,对正常口腔细胞毒性副作用低。